TRAVERSA SERGIO 4
4 · RELMADA THERAPEUTICS, INC. · Filed Nov 6, 2025
Insider Transaction Report
Form 4
TRAVERSA SERGIO
DirectorChief Executive Officer
Transactions
- Purchase
Common Stock
2025-11-05$2.20/sh+272,500$599,500→ 1,272,500 total
4 · RELMADA THERAPEUTICS, INC. · Filed Nov 6, 2025
Common Stock